IVIEW Therapeutics Inc. is a clinical stage ophthalmology drug development company.
Our novel drug development strategies are centered in:
- Novel extended-release formulations
- Combination therapies based on existing FDA approved drugs
- Exploring topical applications of NCEs or repurposed drugs with a focus on clinically validated targets
Company Details
- Employees
- 11
- Founded
- -
- Address
- 5 Cedarbrook Dr, Cranbury,new Jersey 08512,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Cranbury, New Jersey
Iview Therapeutics Questions
Iview Therapeutics's website is http://www.iviewtherapeutics.com/
Iview Therapeutics's LinkedIn profile is https://www.linkedin.com/company/iview-therapeutics
Iview Therapeutics has
11 employees.
View email and phone details for 11
employees at Iview Therapeutics.
Iview Therapeutics's industry is
Pharmaceutical Manufacturing
Iview Therapeutics's top competitors are
Exemplify Biopharma, Inc., A Symeres Company,
Salix Pharmaceuticals,
Neurotez, Inc.,
Novelstar Pharmaceuticals Inc.,
Palatin Technologies,
Aprea Therapeutics,
Klus Pharma Inc.,
Praxgen Pharmaceuticals,
Cyclacel Pharmaceuticals, Inc.,
Shanton Pharma.
Iview Therapeutics's categories are Pharmaceutical Manufacturing
Iview Therapeutics's founding year is 2015
